← back to search

Abi Beane

Child Welfare Society of Kenya · US
Area of research
Epidemiology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Sepsis Diagnosis and Treatment, Respiratory Support and Mechanisms, COVID-19 Clinical Research Studies, and Global Maternal and Child Health.
h-index
36
citations
5,782
works
193
NIH funding
primary concept
Medicine
email

Recent publications

Awake Prone Positioning in Adults With COVID-19
JAMA Internal Medicine 2025cited by 15position: middledoi
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and Outcomes
Annals of the American Thoracic Society 2025cited by 7position: middledoi
Using the Observational Medical Outcomes Partnership Common Data Model for a multi-registry intensive care unit benchmarking federated analysis: lessons learned
JAMIA Open 2025cited by 3position: middledoi
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
JAMA 2023cited by 97position: middledoi
Critical illness at the emergency department of a Tanzanian national hospital in a three-year period 2019–2021
BMC Emergency Medicine 2023cited by 9position: middledoi
Barriers to Quality Perioperative Care Delivery in Low- and Middle-Income Countries: A Qualitative Rapid Appraisal Study
Anesthesia & Analgesia 2022cited by 23position: middledoi
Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care
BMC Health Services Research 2022cited by 16position: middledoi
The burden of respiratory conditions in the emergency department of Muhimbili National Hospital in Tanzania in the first two years of the COVID-19 pandemic: A cross sectional descriptive study
PLOS Global Public Health 2022cited by 5position: middledoi
Cardiovascular Health and Atrial Fibrillation or Flutter: A Cross-Sectional Study from ELSA-Brasil
Figshare 2022cited by 4position: middledoi
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
JAMA 2021cited by 718position: middledoi
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Intensive Care Medicine 2021cited by 99position: middledoi
Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multicentre, observational study
ERJ Open Research 2021cited by 68position: middledoi
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
JAMA 2020cited by 882position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rashan Haniffa · Montreal Heart Institute4 papers (2022–2025) · 3 papers (2022–2023) · 3 papers (2022–2023)Tim Baker · Muhimbili University of Health and Allied Sciences3 papers (2022–2023) · 2 papers (2022–2023)Hendry R. Sawe · University of Cape Town2 papers (2022–2023) · 2 papers (2022–2023) · 2 papers (2022–2023)Gillian J. Bedwell · University of Cape Town1 papers (2022–2022) · 1 papers (2022–2022) · 1 papers (2025–2025)Alexandra Medline · Beth Israel Deaconess Medical Center1 papers (2025–2025)Jeanine Condo · Tulane University1 papers (2025–2025)Stephen B. Gordon · University of Liverpool1 papers (2025–2025) · 1 papers (2025–2025) · 1 papers (2022–2022) · 1 papers (2025–2025) · 1 papers (2022–2022) · 1 papers (2022–2022)Bethany Hedt‐Gauthier · University of North Carolina at Chapel Hill1 papers (2025–2025)